Affinity DataKi: 0.220nM ΔG°: -55.1kJ/molepH: 7.4 T: 2°CAssay Description:Aliquots of cell membranes (90 ug) were incubated at 25 °C for
180 min in 500 uL of binding buffer (50 mM Tris-HCl, 5 mM MgCl2, 1 mM
EDTA, 2 un...More data for this Ligand-Target Pair
Affinity DataKi: 72nMpH: 7.4Assay Description:For A1 adenosine receptors, 40 mg of protein were incubated for 60 min at 25°C with [3H]DPCPX 0.5 nM (Kd = 0.4 nM) and increasing concentrations...More data for this Ligand-Target Pair
Affinity DataKi: 73nM ΔG°: -40.7kJ/molepH: 7.4 T: 2°CAssay Description:Aliquots of cell membranes (90 ug) were incubated at 25 °C for
180 min in 500 uL of binding buffer (50 mM Tris-HCl, 5 mM MgCl2, 1 mM
EDTA, 2 un...More data for this Ligand-Target Pair
Affinity DataKi: 91nMpH: 7.4Assay Description:For A1 adenosine receptors, 40 mg of protein were incubated for 60 min at 25°C with [3H]DPCPX 0.5 nM (Kd = 0.4 nM) and increasing concentrations...More data for this Ligand-Target Pair
Affinity DataKi: 190nMpH: 7.4Assay Description:For A1 adenosine receptors, 40 mg of protein were incubated for 60 min at 25°C with [3H]DPCPX 0.5 nM (Kd = 0.4 nM) and increasing concentrations...More data for this Ligand-Target Pair
Affinity DataKi: 224nMpH: 7.4Assay Description:For A1 adenosine receptors, 40 mg of protein were incubated for 60 min at 25°C with [3H]DPCPX 0.5 nM (Kd = 0.4 nM) and increasing concentrations...More data for this Ligand-Target Pair
Affinity DataKi: 292nMpH: 7.4Assay Description:For A1 adenosine receptors, 40 mg of protein were incubated for 60 min at 25°C with [3H]DPCPX 0.5 nM (Kd = 0.4 nM) and increasing concentrations...More data for this Ligand-Target Pair
Affinity DataKi: 413nMpH: 7.4Assay Description:For A1 adenosine receptors, 40 mg of protein were incubated for 60 min at 25°C with [3H]DPCPX 0.5 nM (Kd = 0.4 nM) and increasing concentrations...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-28.5kJ/molepH: 7.4 T: 2°CAssay Description:Aliquots of cell membranes (90 ug) were incubated at 25 °C for
180 min in 500 uL of binding buffer (50 mM Tris-HCl, 5 mM MgCl2, 1 mM
EDTA, 2 un...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-28.5kJ/molepH: 7.4 T: 2°CAssay Description:Aliquots of cell membranes (90 ug) were incubated at 25 °C for
180 min in 500 uL of binding buffer (50 mM Tris-HCl, 5 mM MgCl2, 1 mM
EDTA, 2 un...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-28.5kJ/molepH: 7.4 T: 2°CAssay Description:Aliquots of cell membranes (90 ug) were incubated at 25 °C for
180 min in 500 uL of binding buffer (50 mM Tris-HCl, 5 mM MgCl2, 1 mM
EDTA, 2 un...More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+4nM ΔG°: >-28.5kJ/molepH: 7.4 T: 2°CAssay Description:Aliquots of cell membranes (90 ug) were incubated at 25 °C for
180 min in 500 uL of binding buffer (50 mM Tris-HCl, 5 mM MgCl2, 1 mM
EDTA, 2 un...More data for this Ligand-Target Pair
Affinity DataIC50: 28nMpH: 7.4 T: 2°CAssay Description:.(R)- and (S)-(4-Fluorophenyl)(4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)methanol was tested in a radioligand binding assay, according to th...More data for this Ligand-Target Pair
Affinity DataKd: 28.5nMpH: 7.4 T: 2°CAssay Description:.(R)- and (S)-(4-Fluorophenyl)(4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)methanol was tested in a radioligand binding assay, according to th...More data for this Ligand-Target Pair
Affinity DataKd: 1.42nMpH: 7.4 T: 2°CAssay Description:.(R)- and (S)-(4-Fluorophenyl)(4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)methanol was tested in a radioligand binding assay, according to th...More data for this Ligand-Target Pair
Affinity DataIC50: 1.55nMpH: 7.4 T: 2°CAssay Description:.(R)- and (S)-(4-Fluorophenyl)(4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)methanol was tested in a radioligand binding assay, according to th...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 5.90nM ΔG°: -47.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 6.60nM ΔG°: -46.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 8.90nM ΔG°: -46.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 10.3nM ΔG°: -45.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 12nM ΔG°: -45.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 12.1nM ΔG°: -45.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 15.2nM ΔG°: -44.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 16.5nM ΔG°: -44.4kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 32.4nM ΔG°: -42.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 40.4nM ΔG°: -42.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 41.5nM ΔG°: -42.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 52nM ΔG°: -41.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 83.2nM ΔG°: -40.4kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 110nM ΔG°: -39.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 114nM ΔG°: -39.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 160nM ΔG°: -38.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 236nM ΔG°: -37.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 315nM ΔG°: -37.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 470nM ΔG°: -36.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 500nM ΔG°: -36.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 560nM ΔG°: -35.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
US Patent
Affinity DataKi: 1.53E+3nM ΔG°: -33.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
Affinity DataKi: 410nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
Affinity DataKi: 786nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
Affinity DataKi: 1.19E+3nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
Affinity DataKi: 1.61E+3nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
Affinity DataKi: 4.69E+3nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
Affinity DataKi: 4.69E+3nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
Affinity DataKi: 0.00300nMAssay Description:Binding affinity at cloned human adenosine A3 receptor expressed in HEK-293 cells was determined using [125I]-AB-MECA as radioligandMore data for this Ligand-Target Pair
Affinity DataKi: 0.0100nMAssay Description:Displacement of [3H]-MRE 3008-F20 from Human Adenosine A3 receptor expressed in HEK-293 cellsMore data for this Ligand-Target Pair
Affinity DataKi: 0.0100nMAssay Description:Antagonist activity at human adenosine A3 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 0.0100nMAssay Description:Displacement of [3H]MRE-3008-F20 from human adenosine A3 receptor expressed in CHO cells after 120 mins by scintillation counterMore data for this Ligand-Target Pair
Affinity DataKi: 0.0100nMAssay Description:Displacement of [125I]I-AB-MECA from human recombinant adenosine A3 receptor expressed in CHO cells after 60 mins by gamma counterMore data for this Ligand-Target Pair
Affinity DataKi: 0.0140nMAssay Description:Displacement of [3H]MRE3008-F20 from human adenosine A3 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair